Cheng-Liang Peng

Title: Innovations of Cheng-Liang Peng in Medical Imaging and Treatment

Introduction

Cheng-Liang Peng is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of medical imaging and treatment, particularly through his innovative patents. With a total of three patents to his name, Peng's work focuses on advanced methods for diagnosing and treating diseases related to the CXCR4 receptor.

Latest Patents

One of Cheng-Liang Peng's latest patents is a complex, contrast agent, and method for treating diseases related to the CXCR4 receptor. This invention is designed to bind the CXCR4 receptor and serves as a medicament for the diagnosis and treatment of cancers and other conditions associated with this receptor. Another significant patent is the dual-targeted carbonic anhydrase IX complex and its corresponding contrast agent. This dual-targeted complex includes a carbonic anhydrase IX (CA9) binding peptide, a sulfonamide derivative, and a metal chelating agent, showcasing potential for use as a molecular nuclear drug.

Career Highlights

Cheng-Liang Peng is affiliated with the Institute of Nuclear Energy Research, which operates under the Atomic Energy Council of the Executive Yuan in Taiwan. His work at this esteemed institution has allowed him to focus on groundbreaking research in nuclear medicine and imaging technologies.

Collaborations

Peng collaborates with esteemed colleagues such as Tsai-Yueh Luo and Chien-Chung Hsia, contributing to a dynamic research environment that fosters innovation and development in medical technologies.

Conclusion

Cheng-Liang Peng's contributions to medical imaging and treatment through his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in the diagnosis and treatment of diseases, particularly in oncology.